SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-24-008374
Filing Date
2024-02-16
Accepted
2024-02-16 16:31:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 ny20016597x2_424b3.htm 424B3 209648
2 logo_ocuphire.jpg GRAPHIC 60098
  Complete submission text file 0001140361-24-008374.txt   293515
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-276462 | Film No.: 24648889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)